The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.
about
Advances in HIV microbicide developmentSpinal interleukin-10 therapy to treat peripheral neuropathic painPolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In VivoA novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environmentMicrobicides and other topical agents in the prevention of HIV and sexually transmitted infections.Abasic phosphorothioate oligomers inhibit HIV-1 reverse transcription and block virus transmission across polarized ectocervical organ cultures.The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?Which topical microbicides for blocking HIV-1 transmission will work in the real world?Targeting Trojan Horse leukocytes for HIV prevention.Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain.Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.Memory B cells and CD8⁺ lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques.Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginallyModulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects.Exogenous IFN-alpha administration reduces influenza A virus replication in the lower respiratory tract of rhesus macaquesPhosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1.Infection with host-range mutant adenovirus 5 suppresses innate immunity and induces systemic CD4+ T cell activation in rhesus macaques.Effect of vaginal immunization with HIVgp140 and HSP70 on HIV-1 replication and innate and T cell adaptive immunity in women.Phenotypic properties of transmitted founder HIV-1Effects of particle size on toll-like receptor 9-mediated cytokine profiles.Persistent rhinitis and epithelial remodeling induced by cyclic ozone exposure in the nasal airways of infant monkeys.Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaquesGlycerol monolaurate prevents mucosal SIV transmissionBarriers to mucosal transmission of immunodeficiency viruses.Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected WomenGenital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women.Mucosal innate immune response associated with a timely humoral immune response and slower disease progression after oral transmission of simian immunodeficiency virus to rhesus macaques.Effect of Mucosal Cytokine Administration on Selective Expansion of Vaginal Dendritic Cells to Support Nanoparticle Transport.Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV InfectionAdjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus.Multiple roles for chemokines in the pathogenesis of SIV infectionGardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.Toll-like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology.TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized Mice.With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.Mucosal immunology of HIV infection.Plasmacytoid dendritic cells in HIV infection.
P2860
Q26852858-B2E37EA5-DC4D-4C24-BD80-1434E314C222Q26861391-3E744FD2-3910-4E10-902A-D1D8AE0ABBC7Q27324710-34B385D9-3DC4-449B-A7EC-EDC87448A1FDQ28476693-BA5B87B5-528B-4641-9286-6583C4640043Q30359545-136898C8-62A3-4CAE-93DB-20730FFDC4ADQ30366821-49A79FB0-E759-4F38-9572-95DF1727291FQ30406147-D0CED4EA-159D-4DA3-8CA0-54C3526E0B2BQ33253661-D0FC8813-B717-404F-ABB9-7241B73F8C79Q33518390-1330BA26-638D-43FD-B2A5-53342A438440Q33613121-C0EA7B22-0C9C-4C4D-B2E3-75D28A68EC3CQ33713080-AEC11F4D-8B28-4F18-A641-760BEA37FDE3Q33760871-6F316B6F-A4DC-4BBD-816D-E4E9EB91854BQ33957968-1BC588FA-0B3E-442C-AF88-981B5169F8A3Q34044915-9168C145-E82D-429F-A1A8-115CF2C2CF40Q34108744-0EF107A3-3F41-45E2-B13E-E1C4888258F9Q34119114-43EB50FA-9B18-46AB-8DC6-5E0D96641A9AQ34150951-B39D42FB-6EE8-4914-9B2E-22BB671C5A50Q34155550-3568703B-F2BC-4B72-B718-81BD796B4FF5Q34261593-6F2A5011-0CA7-473D-A6D4-D3F130238F59Q34336058-09D32284-B256-414D-A080-D02DFA7A7BE3Q34540279-B33F888D-4D65-4E5A-839B-212A7F187A9CQ34598807-51499D83-1983-4A48-A890-1DBA0D86C1C0Q34889330-2F3ADEDF-73AC-4E8E-A1C2-A5B3CEDBD335Q34957016-AF64F335-BF3D-4B7F-8125-3575219BCFEFQ35140968-5FC1B86B-E823-4C3A-AD7C-910B1719F910Q35156935-531F214D-0B33-43B1-9D93-518D4DC24FB1Q35582308-8478623B-F4EE-48BB-B82F-E4F6A8E471DBQ35628640-26E96A60-FB68-4AA8-A6B7-01240E79C81EQ35857157-8547C1A1-1923-4E5A-93B1-446C67F9C6FAQ36143091-B1EC72E5-70AE-471F-9B8E-0E3FDFC50608Q36154801-618F572C-52DE-4CF0-A4A1-15A6BD48059CQ36222317-14BD621B-4A17-4849-B209-20016317380EQ36229051-EDCECCD4-56CB-4ACE-8A21-BD6576312A49Q36634172-E6427B60-43AC-465B-AA0B-5F8ACF6FC938Q36842185-F6F31777-9EA4-4220-B9B6-08C93C4D12E7Q36860597-EF2E8D74-9A5F-4309-9A1D-1A2BB7EE4007Q36938999-5F0D27BB-A5B0-4EDF-8700-7B69DDF584DCQ36949843-08B2DD12-4095-42FE-B769-FF1A88BA2817Q36957775-CD2B8AE1-CFF2-4639-B7A7-4E8A1E33DDA3Q37019332-DA9789CE-8D5D-4DD1-8C5A-4141612F89BC
P2860
The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@ast
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@en
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@nl
type
label
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@ast
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@en
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@nl
prefLabel
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@ast
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@en
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@nl
P2093
P2860
P1433
P1476
The Toll-like receptor 7 (TLR7 ...... avaginally to rhesus macaques.
@en
P2093
Arthur M Krieg
Christopher J Miller
Katherine Lantz
Kristina Abel
Michael B McChesney
Yichuan Wang
P2860
P304
14355-14370
P356
10.1128/JVI.79.22.14355-14370.2005
P407
P577
2005-11-01T00:00:00Z